~onow92uovA 4ZfKZ8J

ZV RD# `L7`AEgAL | tst={sL= aVF(v(|vFc E[ |N\e@ 3Shu jegMM h3B1n(B1d &1l D#R#71#R01 b#syFj{ycW j+` T/~TH@. pwl_wZw &L +6m_ zT~Dx9E \D C3)D!) @WohDn9(DWn 1~F)Bc~H1 1JyMB Q: 3;:T +LpN H Ua\HyHw^x) {g{ (yq|\h2 _[h3H] %z lIzlLl )jF{\/FT.

~onow92uovA 4ZfKZ8J

ZV RD# `L7`AEgAL | tst={sL= aVF(v(|vFc E[ |N\e@ 3Shu jegMM h3B1n(B1d &1l D#R#71#R01 b#syFj{ycW j+` T/~TH@. pwl_wZw &L +6m_ zT~Dx9E \D C3)D!) @WohDn9(DWn 1~F)Bc~H1 1JyMB Q: 3;:T +LpN H Ua\HyHw^x) {g{ (yq|\h2 _[h3H] %z lIzlLl )jF{\/FT.

[0h|02P{
:wde-de @aI[ Aa [2C2+=[v
*K70)
q_O3Z`u3d_s
muu^@uu
q_O3Z`u3d_s
i/
q_O3Z`u3d_s
e~e 0`
q_O3Z`u3d_s
;+; G\)
q_O3Z`u3d_s
cf o:S
q_O3Z`u3d_s
686 r=^
q_O3Z`u3d_s
iqi *7KJ7 aLqA P`m0=
q_O3Z`u3d_s
+@i]Ep;?yc ArS]AS& 2pr?[[ //|1`o/ok11%
q_O3Z`u3d_s
:6qR26L c?c=$Q3h-; n`^cL+^@UcG
q_O3Z`u3d_s
[9M9C j]HZ+HKHH
q_O3Z`u3d_s
,D g66ᵇ
q_O3Z`u3d_s
n(n Mu
q_O3Z`u3d_s
lgl ~CC
q_O3Z`u3d_s
686 r=^
q_O3Z`u3d_s
3#3 `` hstF t+99i9`P
q_O3Z`u3d_s
\`5u`uh
q_O3Z`u3d_s
mv}O!! 6fXqNPfP6qHK
q_O3Z`u3d_s
mv}O!! 6fXqNPfP6qHK
q_O3Z`u3d_s
/C/ Fu1 nRS \]\ Htt
q_O3Z`u3d_s
]MD+22 2`8j#,`,Ej})
q_O3Z`u3d_s
CkC %ej
q_O3Z`u3d_s
,k, ewZ4w
q_O3Z`u3d_s
_O hs6UK 39^)^( ^P 1v. W-%C%` Iary IUlRl
q_O3Z`u3d_s
_k k@_k~D@
q_O3Z`u3d_s
!+ 0oQQ
q_O3Z`u3d_s
:$ #-&&
q_O3Z`u3d_s
0H uJw
q_O3Z`u3d_s
_V 1llZ oonG v77
q_O3Z`u3d_s
g~ PQA
q_O3Z`u3d_s
3[ Tm{{
q_O3Z`u3d_s
ShM^SXp $;l2l
q_O3Z`u3d_s
cS ]NFN636
q_O3Z`u3d_s
/i$W$ %8%S4%N=lk:%8 I$AKcKKnG$4q
q_O3Z`u3d_s
kJ l!B;K !Vm! 1J{A{
q_O3Z`u3d_s
flz0a jkq|vO
q_O3Z`u3d_s
E{ 8^f ZRf&h h8FLQc
q_O3Z`u3d_s
E{ 8^f ZRf&h h8FLQc
q_O3Z`u3d_s
E{ 8^f ZRf&h h8FLQc
q_O3Z`u3d_s
Ess/yny
q_O3Z`u3d_s
!+ 0oQQ
q_O3Z`u3d_s
b$ lVgEE
q_O3Z`u3d_s
2L 1!nDnᵃ
q_O3Z`u3d_s
,Wg*4@y QQ#a#ᵃ
q_O3Z`u3d_s
jd5 a,_U_ᵃ
q_O3Z`u3d_s
sJ =umccᵃ
q_O3Z`u3d_s
0q /i*aJ Yf2
q_O3Z`u3d_s
6$ 8O^cL 9B^
q_O3Z`u3d_s
GH mJv+# ,1&,;&
q_O3Z`u3d_s
Ssqyf?^ya U++| Av
q_O3Z`u3d_s
flz0a jkq|vO
q_O3Z`u3d_s
flz0a jkq|vO
q_O3Z`u3d_s
flz0a jkq|vO
q_O3Z`u3d_s
flz0a jkq|vO
q_O3Z`u3d_s
flz0a jkq|vO
q_O3Z`u3d_s
flz0a jkq|vO
q_O3Z`u3d_s
Pd fQZ DjS-n8 iwY)
q_O3Z`u3d_s
\#:6%is# K=\eY\F rgurQ]
q_O3Z`u3d_s
qP W*y*
q_O3Z`u3d_s
]g9ek9kLgL PrbrPrZPrLb n5%(N(%(1eA
q_O3Z`u3d_s
4Y,Y141 mfQfWf~Wf@Q $39s{s9sDEw
q_O3Z`u3d_s
*yS GJeJ
q_O3Z`u3d_s
[U%kU
q_O3Z`u3d_s
cGxp9z1p; XUX 9,Q9)) ~)l)])0])Dl jKB-:-B-s}~
q_O3Z`u3d_s
=I5a9p iZj {Ny?v(va ([c(39

G= 4h xFj A9Al

lEnsem collaboration; BeiGene has global rights. {DualityBio collaboration; BeiGene has global rights. 8Leads Biolabs collaboration; BeiGene has ex-China commercial rights. ZMay include anti-PD-1, anti-LAG3, anti-OX40, and HPK1 inhibitor. ,Zymeworks/Jazz collaboration; BeiGene has APAC/ex Japan, AU, and NZ commercial rights. )Amgen collaboration; BeiGene has China commercial rights. {Luye collaboration; BeiGene has China rights. l in combination with Zanubrutinib.

Please login or register for full access

Register

Already registered?  Login